XML 116 R80.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Commitments and Contingencies - Additional Information (Details) - USD ($) | 1 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2020 | Dec. 31, 2021
Maximum | Research and Development Service Agreement |  |
Commitments And Contingencies Disclosure [Line Items] |  |
Potential payment for milestone |  | $ 1,750,000
Termination payments |  | 500,000
Preclinical Studies and Clinical Trials | MDACC |  |
Commitments And Contingencies Disclosure [Line Items] |  |
Contractual obligation | $ 10,000,000.0 |
Contractual obligation period | 5 years |
Contractual obligation paid |  | $ 3,000,000.0

X
- Definition Commitments and contingencies disclosure. + References No definition available. + Details
Name: | rptx_CommitmentsAndContingenciesDisclosureLineItems
Namespace Prefix: | rptx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Contractual Obligation Paid. + References No definition available. + Details
Name: | rptx_ContractualObligationPaid
Namespace Prefix: | rptx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Contractual obligation period. + References No definition available. + Details
Name: | rptx_ContractualObligationPeriod
Namespace Prefix: | rptx_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Potential payment for milestone. + References No definition available. + Details
Name: | rptx_PotentialPaymentForMilestone
Namespace Prefix: | rptx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Termination payments. + References No definition available. + Details
Name: | rptx_TerminationPayments
Namespace Prefix: | rptx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition All amounts that, per contract, are due to the servicer in exchange for servicing the financial asset and would no longer be received by a servicer if the beneficial owners of the serviced assets (or their trustees or agents) were to exercise their actual or potential authority under the contract to shift the servicing to another servicer. Depending on the servicing contract, those fees may include some or all of the difference between the interest rate collected on the asset being serviced and the rate to be paid to the beneficial owners of the asset. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 860 -SubTopic 50 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=125521744&loc=d3e122596-111746 + Details
Name: | us-gaap_ContractuallySpecifiedServicingFeesAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_ResearchAndDevelopmentArrangementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=rptx_PreclinicalStudiesAndClinicalTrialsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=rptx_TheUniversityOfTexasMDAndersonCancerCenterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |